Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 |
filingDate |
2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea4a951f17af953a2c8ccb5e87e16951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abd04258367e42d2faba5326612aae50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5b142cd14c3899221ac21b0379f620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a20da42227a7bdf3bb976fe7e94a5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd479751d8850a637db624b2e783352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_461f6bc4f10b1e1f0a9f58950cbe5e67 |
publicationDate |
2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DK-2961407-T3 |
titleOfInvention |
SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2 (1H) -ON-DERIVATIVES WITH BOTH 2-ADDRENGE RECEPTOR AGONIST AND M3 MUSCARIN RECEPTOR ANTAGONIST ACTIVITIES |
abstract |
The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof. |
priorityDate |
2013-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |